(R) -ACBI-4
(R) -ACBI-4 is an isomer of ACBI-4. ACBI-4 is a selective GTP-loaded active state of KRAS (KRAS (on) ) PROTAC degrader. ACBI-4 has significant anti-proliferative effect and potently degrades multiple KRAS mutants in cancer cells, such as KRASG12R[1].
Product Specifications
CAS Number
3097973-97-9
UNSPSC
12352005
Target
Drug Isomer; PROTACs; Ras
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway; Others; PROTAC
Field of Research
Cancer
Smiles
CC([C@H](N1N=NC2=C1CC[C@@H](CCCN3C[C@@H](N(CCC3)C4=NC(C5=NOC([C@@]6(C7=C(CCC6)SC(N)=C7C#N)C)=N5)=CC=N4)C)C2)C(N8C[C@@H](C[C@H]8C(NCC9=CC=C%10C(N(N=C%10)C)=C9)=O)O)=O)C
Molecular Formula
C50H63N15O4S
Molecular Weight
970.20
References & Citations
[1]Vetma V, et al. Identification of a Highly Cooperative PROTAC Degrader Targeting GTP-loaded KRAS (on) Alleles[J]. 2025.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
K-Ras; von Hippel-Lindau (VHL)
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15090403 1 Vial
Lentiviral human SMIM12 shRNA (UAS) - Lentiviral human SMIM12 shRNA (UAS) plasmid
Sign In for Pricing
View Details 
AF587-SP 25 µg
Mouse TGF-beta RI/ALK-5 Affinity Purified Polyclonal Ab
Sign In for Pricing
View Details